Patents

US RE47033 E1: Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials

Granted
2018-09-11
Filed
2017-04-17 application 15489613
Type
Reissue · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A pharmaceutical composition comprises a solid adsorbate comprising a drug adsorbed onto a substrate and a lipophilic microphase-forming material. The solid adsorbate may also be co-administered with a lipophilic microphase-forming material to an in vivo use environment. The compositions of the present invention enhance the concentration of drug in a use environment.

Source: PVGPATDIS, file of 2026-04-10 (ipg180911.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Bend Reserch, Inc. 62 patentsUS company or organizationBend, ORPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Walter C. BabcockBend, OR18PVGPATDIS, file of 2026-04-10
Dwayne T. FriesenBend, OR38Person page FUZZY medium confidencePVGPATDIS, file of 2026-04-10
Ravi M. ShankerStonington, CT27PVGPATDIS, file of 2026-04-10
Daniel T. SmitheyBend, OR16PVGPATDIS, file of 2026-04-10

CPC categories

No CPC categories reported.

Assignments and security interests

RecordedWhatFromToReel/frameSource
2023-02-02Name change
Change of name
BEND RESEARCH, INC. signed 2023-01-01LONZA BEND INC. BEND, OR62971/292PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.